Inhibiting TGF-beta signaling restores immune surveillance in the SMA-560 glioma model. - Wikidata - wikimedia - TriplyDB

Inhibiting TGF-beta signaling restores immune surveillance in the SMA-560 glioma model.

Inhibiting TGF-beta signaling restores immune surveillance in the SMA-560 glioma model.

http://www.wikidata.org/entity/Q40128542

about

Immunosuppressive Mechanisms of Malignant Gliomas: Parallels at Non-CNS Sites Prospects of immune checkpoint modulators in the treatment of glioblastoma Clinical Neuropathology mini-review 6-2015: PD-L1: emerging biomarker in glioblastoma?Targeting the transforming growth factor-beta signaling pathway in human cancer.The roles of TGFβ in the tumour microenvironment.Targeting protein kinases in central nervous system disorders Stable luciferase expression does not alter immunologic or in vivo growth properties of GL261 murine glioma cells Chemotherapeutic Targeting of the Transforming Growth Factor-β Pathway in Breast Cancers.Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma.Current trends in targeted therapies for glioblastoma multiforme Recent developments on immunotherapy for brain cancer.Study on the therapeutic effect of neural progenitor cells in mice of a glioma murine model Moxifloxacin modifies corneal fibroblast-to-myofibroblast differentiation Naringenin prevents TGF-β1 secretion from breast cancer and suppresses pulmonary metastasis by inhibiting PKC activation.CX3CL1 and CX3CR1 in the GL261 murine model of glioma: CX3CR1 deficiency does not impact tumor growth or infiltration of microglia and lymphocytes.The Dual Role of TGFβ in Human Cancer: From Tumor Suppression to Cancer Metastasis Prioritization schema for immunotherapy clinical trials in glioblastoma.Combating immunosuppression in glioma PPAR Gamma Activators: Off-Target Against Glioma Cell Migration and Brain Invasion.Advances in Immunotherapy for Glioblastoma Multiforme.Cytokine networks in glioma.TGF-β in the Bone Microenvironment: Role in Breast Cancer Metastases.Microenvironmental clues for glioma immunotherapy.A new hope in immunotherapy for malignant gliomas: adoptive T cell transfer therapy.The Dynamics of Interactions Among Immune and Glioblastoma Cells.PPAR-gamma Thiazolidinedione Agonists and Immunotherapy in the Treatment of Brain Tumors.TGF-β-induced hCG-β regulates redox homeostasis in glioma cells.Differential regulation of TGF-β-induced, ALK-5-mediated VEGF release by SMAD2/3 versus SMAD1/5/8 signaling in glioblastoma Rosiglitazone suppresses glioma cell growth and cell cycle by blocking the transforming growth factor-beta mediated pathway.A Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastoma.Enhancing Adoptive Cell Therapy of Cancer through Targeted Delivery of Small-Molecule Immunomodulators to Internalizing or Noninternalizing Receptors.Trabedersen to target transforming growth factor-beta: when the journey is not the reward, in reference to Bogdahn et al. (Neuro-Oncology 2011;13:132-142).Role of Macrophages in Brain Tumor Growth and Progression.Dock1 promotes the mesenchymal transition of glioma and is modulated by MiR-31.

P2860

Q26798402-32005B2E-1303-46EB-B259-663E2343DCE2 Q28081371-F5354D0F-4F0F-4925-A081-DE9873C37250 Q28084351-B906C4DA-A91F-4BB1-8DAB-665ECE8346E1 Q33517772-94621766-686D-48E9-B959-260B5CDD766C Q33630845-3A8133B3-2463-47BF-8750-109BEBAA6FCE Q33671660-3FF123DB-755F-4AE2-9AB7-2FAE942DF82D Q34645287-33B3DF75-3991-4F84-8217-D8A10926CCDA Q35490960-99549C45-832E-4F96-B924-1A82DB81A0DE Q35815273-63B0B95A-9BFA-4D9F-A6E5-62E8C75986D3 Q35864226-65F73769-2FA0-4F29-B31F-6D1DB70A90BB Q35992355-71871D4D-97DD-4318-9236-AC7C2A236835 Q36650448-DC83D11D-44B1-4DC1-A5A3-6029A21B0E30 Q36681754-681C0CFE-6EC2-4B4C-A589-0574C768E501 Q36758301-D4E1B14F-A95D-4D11-A4E9-8D4231327C4D Q36922514-75F1C57F-C62F-4D77-B67C-D3F78715B57C Q36985643-8DFBF790-ADB4-49D2-B6A3-6DD002196E00 Q37078999-75DD272C-D9CC-46BB-A32E-916E14CF0FDB Q37179415-67CB8C1E-7116-483C-A533-289AC0DAA94C Q37278858-0FD62159-3E67-4C8F-BE43-555CF76CEED8 Q37680966-98D2C724-80C8-4B09-AE98-9025BA51C5B4 Q37886819-6BE06316-4D07-47D1-9867-103FACFFCB48 Q37900199-BF842968-46E1-4BC0-9EC8-1EC000224878 Q38194054-F49A8C32-4C3F-40EF-883C-38CA1C1DD2B0 Q38227889-B74AC97D-392F-4071-A920-8213E1DA99BA Q38557236-504EF21A-6779-49A9-BA7B-9AE66DF03CE7 Q38620031-B94676D2-B24F-4663-A042-8F1AEA5F6969 Q38949348-EACC58BD-796F-4856-BD76-1E97EFB1F700 Q38962204-0956EA8A-568E-4A4E-BDB5-4D94413EBB5F Q39329694-B84B4108-18B8-4385-ADE9-47B1B3B72C4A Q42113451-19C040CA-70D5-47A1-84CB-4B79AB0F5C52 Q42380337-1C55E742-D389-42CE-9A0C-AFF38189A9E9 Q42732702-AC0B8BFA-0631-4E71-A4CC-1DCA47C31853 Q52628012-FA5837C2-F1C0-4D1B-AAB6-9272714BB56A Q55459483-B1633934-2CCF-41FA-8636-E82F8BA840E5

P2860

Inhibiting TGF-beta signaling restores immune surveillance in the SMA-560 glioma model.

http://www.wikidata.org/entity/Q40128542

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Inhibiting TGF-beta signaling restores immune surveillance in the SMA-560 glioma model.

@en

type

label

Inhibiting TGF-beta signaling restores immune surveillance in the SMA-560 glioma model.

@en

prefLabel

Inhibiting TGF-beta signaling restores immune surveillance in the SMA-560 glioma model.

@en

P1433

Q40128542-51ED501E-0C6E-4ECE-ACBA-F78026DCA178

P1476

Q40128542-DC7C2DED-85AF-430C-932A-ADC248729891

P2093

Q40128542-0BB556AA-4595-4421-8B31-1C5F39697E24

Q40128542-196914D1-8878-46EC-B3BB-819EAD47F30F

Q40128542-329B3FD7-699B-466C-BBC5-828F7483787F

Q40128542-34C5E4FE-2FAD-4BB4-8B18-B8E7426519DD

Q40128542-389B7E47-1BA5-4D27-B76D-0E1DF2C393C5

Q40128542-3F07A946-D23A-47B0-8005-79EF4749B40F

Q40128542-4162964A-6666-4FD6-B4CD-3E9CDE27F9C5

Q40128542-4FF339C7-BBB5-4632-9EC6-922C53F207A9

Q40128542-55989F1F-BAE6-44DB-B0D2-83A7A4A8F3CE

Q40128542-65AD4BEF-21A7-4977-996F-318B03D29466

P2860

Q40128542-02F2FE88-3D5F-4FF6-ABA8-434C49F3F3B6

Q40128542-0732240D-E77A-4A2E-97D4-10C16C7D3CE4

Q40128542-12BE0669-9BD8-4697-B488-B84A31548DED

Q40128542-217545BD-6092-4E01-9FAC-FB4FC43B62DA

Q40128542-2C33B9EB-66F6-4E20-9BAC-4D2A6DB72DF3

Q40128542-33850CDF-EDC2-4112-B7D5-8DF0981454AB

Q40128542-359ABDAF-FC65-445A-B8A3-03375AB51CBC

Q40128542-372D9666-EF37-4B0F-B575-6E141C9EA08E

Q40128542-51073452-C7F9-475B-9695-81DBC420D017

Q40128542-6DC74160-98F3-4342-B5C3-CD03525222E7

P304

Q40128542-55866896-9A9A-4C09-A443-701851F52095

P31

Q40128542-274FCF67-225A-4F98-8D47-FE957CADC181

P356

Q40128542-4325FF9D-3BF7-4C2F-AFE3-0126E4B565DA

P433

Q40128542-70B735BC-3E9E-4346-AA83-638CE5A2B58C

P478

Q40128542-4BB4234F-C34E-41CF-A948-79FEA8F0694A

P50

Q40128542-5286EDAF-4CDA-4A58-9AB1-390A2C6076A9

Q40128542-6FC69674-F38E-4D58-AB27-C7425AE0E594

P577

Q40128542-A7188441-B20D-48AE-8719-ED8AEC2F8159

P5875

Q40128542-D5B3D5D0-8BE0-49F6-A5BE-800814E5B869

P698

Q40128542-1A7DAD35-ECF2-4754-AD56-0861F2811016

P932

Q40128542-C6D3DA94-C275-40F5-9C14-7D6A73F2CBAE

P356

15228517-2007-010

P1433

P1476

Inhibiting TGF-beta signaling restores immune surveillance in the SMA-560 glioma model.

@en

P2093

Alison Murphy

http://www.w3.org/2001/XMLSchema#string

Andrew A Protter

http://www.w3.org/2001/XMLSchema#string

Andrew Lam

http://www.w3.org/2001/XMLSchema#string

Ann M Kapoun

http://www.w3.org/2001/XMLSchema#string

Barry Hart

http://www.w3.org/2001/XMLSchema#string

Darin E Kizer

http://www.w3.org/2001/XMLSchema#string

Darren H Wong

http://www.w3.org/2001/XMLSchema#string

Glenn McEnroe

http://www.w3.org/2001/XMLSchema#string

Heather K Webb

http://www.w3.org/2001/XMLSchema#string

Irene Kerr

http://www.w3.org/2001/XMLSchema#string

P2860

Complementary DNA for human glioblastoma-derived T cell suppressor factor, a novel member of the transforming growth factor-beta gene family

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Depressed cell-mediated immunity in patients with primary intracranial tumors. Characterization of a humoral immunosuppressive factor.

Trends in incidence of primary brain tumors in the United States, 1985-1994.

Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials.

Current and future trials of the EORTC brain tumor group.

Immune defects observed in patients with primary malignant brain tumors.

Characterization of gene expression profiles associated with glioma progression using oligonucleotide-based microarray analysis and real-time reverse transcription-polymerase chain reaction

Role of transforming growth factor Beta in human cancer.

Control of human glioma cell growth, migration and invasion in vitro by transforming growth factor beta 1

P304

259-270

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1215/15228517-2007-010

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

P577

2007-05-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6311148

http://www.w3.org/2001/XMLSchema#string

P698

17522330

http://www.w3.org/2001/XMLSchema#string

P932

1907409

http://www.w3.org/2001/XMLSchema#string